Surgery Partners, Inc.

SGRY Healthcare Medical Care Facilities

Surgery Partners, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.3 billion, up 6.24% from fiscal 2024.

Revenue
+2.75%
EPS
−500.0%
Free cash flow
−60.6%
Total debt
+4.92%

Quarter to June 2026, against a year earlier

23.18 0.02 +0.09%
Market cap
$3.0B
P/E
0.0×
Fwd P/E
−35.3×
Dividend yield
—
F-score
4/9
Altman Z
0.75
Beneish M
−2.52
Dividend safety
4/100

Surgery Partners, Inc. (SGRY) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, Surgery Partners, Inc. (SGRY) trades at a P/B ratio of 1.0×. Over the past ten years it has ranged from 0.2× (March 2020) to 39.6× (December 2015); the current reading is higher than 43% of that period. That is below the Medical Care Facilities industry median of 3.1× and below the Healthcare sector median of 2.3×.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2025 0.6× (24.85%)
FY2024 0.8× (36.20%)
FY2023 1.3× 59.22%
FY2022 0.8× (58.13%)
FY2021 2.0× 22.44%
FY2020 1.6× 108.65%
FY2019 0.8× 79.67%
FY2018 0.4× (11.33%)
FY2017 0.5× (78.95%)
FY2016 2.3× (7.58%)

Quarterly newest first

Period P/B ratio Change
Jun 2026 0.7× 41.28%
Mar 2026 0.5× (21.32%)
Dec 2025 0.6× (28.35%)
Sep 2025 0.9× (2.04%)
42 more quarters

Against its own ten years

Low 0.2× High 39.6×
Ten-year median 1.1×
Current reading's percentile 44

P/B ratio against peers

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on SGRY